John C. Byrd

1.6k citations
4 papers · 288 indexed · h-index 4
Topics
Lymphoma Diagnosis and Treatment (4 papers)T-cell and Retrovirus Studies (2 papers)Viral-associated cancers and disorders (2 papers)
Partner nations
United StatesIndiaCanada

In The Last Decade

John C. Byrd

4 papers receiving 286 citations

Peers

John C. Byrd
Comparison fields: 5 of 31
  • Pathology and Forensic Medicine 251
  • Oncology 182
  • Genetics 106
  • Pulmonary and Respiratory Medicine 54
  • Neurology 43
Replace Florence Broussais‐Guillaumot with:
Florence Broussais‐Guillaumot France
M. van ‘t Veer Netherlands
S. Wiedenmann Germany
Olaf Determann Germany
Viola Pöschel Germany
Maya Hacini France
Alessandra Cuttica Italy
Pär Josefsson Denmark
Antonella Anastasia Italy
Nikolaos Harhalakis Greece
John C. Byrd relative to Florence Broussais‐Guillaumot France Florence Broussais‐Guillaumot's profile →
Citations per field
00.5×1.5×2.3×
Florence Broussais‐Guillaumot · 1×
Citations per year

Countries citing papers authored by John C. Byrd

Since Specialization
Citations

This map shows the geographic impact of John C. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Byrd more than expected).

Fields of papers citing papers by John C. Byrd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Byrd. The network helps show where John C. Byrd may publish in the future.

Co-authorship network of co-authors of John C. Byrd

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Byrd. A scholar is included among the top collaborators of John C. Byrd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Byrd. John C. Byrd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 15
2 26
3 110
4 137

About John C. Byrd

John C. Byrd is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 4 papers that have together received 288 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (4 papers), T-cell and Retrovirus Studies (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (251 citations), Genetics (106 citations) and Oncology (182 citations). John C. Byrd has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Ann S. LaCasce, Wendy Stock, David D. Hurd, Bruce D. Cheson, Nancy L. Bartlett, Kristie A. Blum, George P. Canellos, Charles Linker, Donna Niedzwiecki and Michael E. Kelly. Their work appears in journals such as Journal of Clinical Oncology, Blood and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026